$KITL
Kisses From Italy Inc. Stock $kitl

$kitl Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000168316824004860 Filed on July 15, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2023 Q4
Revenue	$715.00	$33.12K	$22.55K
YoY Change	-97.31%	-71.32%	-71.8%
Cost Of Revenue	$3.070K	$16.50K	$21.75K
YoY Change	-62.87%	-71.98%	-57.34%
Gross Profit	-$2.354K	$16.62K	$800.00
YoY Change	-112.86%	-70.62%	-97.24%
Gross Profit Margin	-329.23%	50.19%	3.55%
Selling, General & Admin		$82.75K	$513.7K
YoY Change		-84.41%	328.3%
% of Gross Profit		497.77%	64207.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
% of Gross Profit		0.0%	0.0%
Operating Expenses	$10.33K	$117.0K	$513.7K
YoY Change	-99.26%	-77.98%	326.45%
Operating Profit	-$12.69K	-$100.4K	-$512.9K
YoY Change	-99.08%	-78.86%	460.69%
Interest Expense		-$34.87K	-$77.16K
YoY Change		-88.74%	-418.84%
% of Operating Profit
Other Income/Expense, Net	-$19.52K	-$9.768K	$71.96K
YoY Change	-97.65%	-97.96%
Pretax Income	-$32.20K	-$110.1K	-$350.0K
YoY Change	-98.54%	-88.44%	963.86%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$32.20K	-$110.1K	-$317.1K
YoY Change	-98.57%	-88.41%	3565.55%
Net Earnings / Revenue	-4503.64%	-332.49%	-1406.08%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	372.9M shares	354.8M shares	326.0M shares
Diluted Shares Outstanding	398.2M shares	354.8M shares

Balance Sheet

Concept	2024 Q3	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.010K	$24.84K
YoY Change		-94.13%	-92.34%
Cash & Equivalents	$810.00	$2.008K	$24.84K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$1.219K	$8.067K	$11.92K
Prepaid Expenses
Receivables	$3.376K	$3.386K	$5.117K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$5.405K	$13.46K	$41.88K
YoY Change	-97.06%	-88.05%	-89.57%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$1.092K	$2.745K
YoY Change	-100.0%	-60.22%	0.0%
Total Long-Term Assets	$0.00	$1.092K	$43.60K
YoY Change	-100.0%	-99.78%	-91.63%
TOTAL ASSETS
Total Short-Term Assets	$5.405K	$13.46K	$41.88K
Total Long-Term Assets	$0.00	$1.092K	$43.60K
Total Assets	$5.405K	$14.55K	$85.47K
YoY Change	-99.14%	-97.61%	-90.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$136.8K	$101.5K	$114.5K
YoY Change	33.97%	40.27%	32.48%
Accrued Expenses	$101.1K	$60.32K	$42.05K
YoY Change	-18.36%	-54.46%	-71.85%
Deferred Revenue
YoY Change
Short-Term Debt		$407.5K	$425.0K
YoY Change		24.78%	-43.38%
Long-Term Debt Due		$352.5K	$250.0K
YoY Change
Total Short-Term Liabilities	$979.9K	$921.8K	$831.5K
YoY Change	34.49%	28.79%	-24.77%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$102.5K
YoY Change		-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00	$102.5K
YoY Change		-100.0%	-76.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$979.9K	$921.8K	$831.5K
Total Long-Term Liabilities		$0.00	$102.5K
Total Liabilities	$979.9K	$921.8K	$934.0K
YoY Change	-29.85%	-32.76%	-39.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.60M	-$19.66M	-$19.54M
YoY Change	1.93%	25.54%	32.9%
Common Stock	$407.8K	$372.9K	$336.8K
YoY Change	34.68%	77.4%	77.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$941.5K	-$874.2K	-$815.5K
YoY Change
Total Liabilities & Shareholders Equity	$5.405K	$14.55K	$85.47K
YoY Change	-99.14%	-97.61%	-90.73%

Cashflow Statement

Concept	2024 Q3	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$32.20K	-$110.1K	-$317.1K
YoY Change	-98.57%	-88.41%	3565.55%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Cash From Operating Activities		-$55.25K	-$127.0K
YoY Change		-80.96%	82.1%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$32.42K	43.99K
YoY Change
NET CHANGE
Cash From Operating Activities		-$55.25K	-127.0K
Cash From Investing Activities			0.000
Cash From Financing Activities		$32.42K	43.99K
Net Change In Cash		-$22.83K	-82.99K
YoY Change		-92.13%	-24.95%
FREE CASH FLOW
Cash From Operating Activities		-$55.25K	-$127.0K
Capital Expenditures			$0.00
Free Cash Flow			-$127.0K
YoY Change			14.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 2000
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 2000
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33130
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33130
CY2024Q1	dei	City Area Code CityAreaCode	305
CY2024Q1	dei	City Area Code CityAreaCode	305
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	423-7129
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	372920331	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24842	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	8067	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11917	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	13461	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	41876	usd
CY2024Q1	kitl	Equipment Not In Service EquipmentNotInService	0	usd
CY2023Q4	kitl	Equipment Not In Service EquipmentNotInService	40852	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1092	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2745	usd
CY2024Q1	us-gaap	Assets Assets	14553	usd
CY2023Q4	us-gaap	Assets Assets	85473	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	101464	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	114456	usd
CY2024Q1	kitl	Notes Payable Related Party NotesPayableRelatedParty	352497	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	831505	usd
CY2024Q1	kitl	Notes Payable Long Term Related Party NotesPayableLongTermRelatedParty	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	934002	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	372920	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18407728	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-874247	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-815544	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-32985	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-32985	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-848529	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14553	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	85473	usd
CY2024Q1	us-gaap	Revenues Revenues	33119	usd
CY2023Q1	us-gaap	Revenues Revenues	115460	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	16495	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	58871	usd
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	372920331	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3386	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5117	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	8067	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11917	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	13461	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	41876	usd
CY2024Q1	kitl	Equipment Not In Service EquipmentNotInService	0	usd
CY2023Q4	kitl	Equipment Not In Service EquipmentNotInService	40852	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1092	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2745	usd
CY2024Q1	us-gaap	Assets Assets	14553	usd
CY2023Q4	us-gaap	Assets Assets	85473	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	101464	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	114456	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60324	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42049	usd
CY2024Q1	kitl	Notes Payable Related Party NotesPayableRelatedParty	352497	usd
CY2023Q4	kitl	Notes Payable Related Party NotesPayableRelatedParty	250000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	407500	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	425000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	921785	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	831505	usd
CY2024Q1	kitl	Notes Payable Long Term Related Party NotesPayableLongTermRelatedParty	0	usd
CY2023Q4	kitl	Notes Payable Long Term Related Party NotesPayableLongTermRelatedParty	102497	usd
CY2024Q1	us-gaap	Liabilities Liabilities	921785	usd
CY2023Q4	us-gaap	Liabilities Liabilities	934002	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	101464	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	114456	usd
CY2024Q1	kitl	Notes Payable Related Party NotesPayableRelatedParty	352497	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	921785	usd
CY2024Q1	kitl	Notes Payable Long Term Related Party NotesPayableLongTermRelatedParty	0	usd
CY2023Q4	kitl	Notes Payable Long Term Related Party NotesPayableLongTermRelatedParty	102497	usd
CY2024Q1	us-gaap	Liabilities Liabilities	921785	usd
CY2023Q4	us-gaap	Liabilities Liabilities	934002	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	372920331	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	372920331	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	372920	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	336763	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18392470	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19655070	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19544952	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-874247	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-815544	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-32985	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-907232	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-848529	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14553	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	85473	usd
CY2024Q1	us-gaap	Revenues Revenues	33119	usd
CY2023Q1	us-gaap	Revenues Revenues	115460	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	16495	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	58871	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	16624	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	56589	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	206700	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	18532	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	53440	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	20777	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	32357	usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	19726	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	150757	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34221	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23718	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87501	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	116974	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	531283	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-100350	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-474694	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-34868	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	372920331	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	336763187	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	372920	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18407728	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18392470	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19544952	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-874247	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-815544	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-32985	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-32985	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-848529	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14553	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	85473	usd
CY2024Q1	us-gaap	Revenues Revenues	33119	usd
CY2023Q1	us-gaap	Revenues Revenues	115460	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	16495	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	58871	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	16624	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	56589	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	18532	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	32357	usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	19726	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	150757	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34221	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23718	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87501	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	116974	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	531283	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-100350	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-474694	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-34868	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-243285	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25100	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-168060	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66342	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9768	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-477687	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110118	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-952381	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-110118	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1883	usd
CY2023Q1	kitl	Reduction Of Accounts Payable And Accrued Interest With Common Stock ReductionOfAccountsPayableAndAccruedInterestWithCommonStock	15050	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zBjdlIHgM3eh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zKIOZ6JPA3Wa">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable and the allowance for doubtful accounts, inventories, valuation of financial instruments, income taxes, and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these condensed consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Gross Profit GrossProfit	16624	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	56589	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	206700	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	32357	usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	19726	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	150757	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34221	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23718	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87501	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	116974	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	531283	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-100350	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-474694	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-34868	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-243285	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25100	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-168060	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66342	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9768	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-477687	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110118	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-952381	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-110118	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-952381	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1883	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-110118	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	354841759	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	354841759	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	194550922	shares
CY2023Q1	kitl	Common Stock Issued For Accounts Payable CommonStockIssuedForAccountsPayable	15050	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Shares Value IssuanceOfCommonStockAsFinancingCommitmentSharesValue	198000	usd
CY2023Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock Value ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStockValue	381860	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1883	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-848529	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	19000	usd
CY2024Q1	kitl	Issuance Of Shares On Companys Equity Line Of Credit IssuanceOfSharesOnCompanysEquityLineOfCredit	32415	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-110118	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-243285	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25100	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-168060	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66342	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9768	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-477687	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110118	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-952381	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-110118	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-952381	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1883	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-110118	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	354841759	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	194550922	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	354841759	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	194550922	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-610962	usd
CY2023Q1	kitl	Common Stock Issued For Accounts Payable CommonStockIssuedForAccountsPayable	15050	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Shares Value IssuanceOfCommonStockAsFinancingCommitmentSharesValue	198000	usd
CY2023Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock Value ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStockValue	381860	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1883	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-761732	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-848529	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	19000	usd
CY2024Q1	kitl	Issuance Of Shares On Companys Equity Line Of Credit IssuanceOfSharesOnCompanysEquityLineOfCredit	32415	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-110118	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-907232	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-110118	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-952381	usd
CY2024Q1	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	168060	usd
CY2024Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	0	usd
CY2023Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	206700	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66342	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34221	usd
CY2024Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	1500	usd
CY2023Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	198000	usd
CY2024Q1	kitl	Sale Of Equipment SaleOfEquipment	6630	usd
CY2023Q1	kitl	Sale Of Equipment SaleOfEquipment	0	usd
CY2024Q1	kitl	Issuance Of Financing Commitment Warrants And Exercises IssuanceOfFinancingCommitmentWarrantsAndExercises	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-110118	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	354841759	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	194550922	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	354841759	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	194550922	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-610962	usd
CY2023Q1	kitl	Common Stock Issued For Accounts Payable CommonStockIssuedForAccountsPayable	15050	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Shares Value IssuanceOfCommonStockAsFinancingCommitmentSharesValue	198000	usd
CY2023Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock Value ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStockValue	381860	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1883	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-848529	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	19000	usd
CY2024Q1	kitl	Issuance Of Shares On Companys Equity Line Of Credit IssuanceOfSharesOnCompanysEquityLineOfCredit	32415	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-110118	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-907232	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-110118	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-952381	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	168060	usd
CY2024Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	0	usd
CY2023Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	206700	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-0	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66342	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34221	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	1500	usd
CY2023Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	198000	usd
CY2024Q1	kitl	Sale Of Equipment SaleOfEquipment	6630	usd
CY2024Q1	kitl	Issuance Of Financing Commitment Warrants And Exercises IssuanceOfFinancingCommitmentWarrantsAndExercises	0	usd
CY2023Q1	kitl	Issuance Of Financing Commitment Warrants And Exercises IssuanceOfFinancingCommitmentWarrantsAndExercises	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1731	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	202	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3849	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1141	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12991	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1007	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1653	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-0	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18276	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24865	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55249	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	32415	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32415	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-907232	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-110118	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-952381	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527	usd
CY2024Q1	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	168060	usd
CY2024Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	0	usd
CY2023Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	206700	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66342	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34221	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	1500	usd
CY2023Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	198000	usd
CY2024Q1	kitl	Sale Of Equipment SaleOfEquipment	6630	usd
CY2023Q1	kitl	Sale Of Equipment SaleOfEquipment	0	usd
CY2024Q1	kitl	Issuance Of Financing Commitment Warrants And Exercises IssuanceOfFinancingCommitmentWarrantsAndExercises	0	usd
CY2023Q1	kitl	Issuance Of Financing Commitment Warrants And Exercises IssuanceOfFinancingCommitmentWarrantsAndExercises	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	202	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3849	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1141	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12991	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1007	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1653	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18276	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55249	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-290238	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32415	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22834	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24842	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2008	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34255	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	19000	usd
CY2024Q1	kitl	Reduction Of Accounts Payable And Accrued Interest With Common Stock ReductionOfAccountsPayableAndAccruedInterestWithCommonStock	0	usd
CY2023Q1	kitl	Reduction Of Accounts Payable And Accrued Interest With Common Stock ReductionOfAccountsPayableAndAccruedInterestWithCommonStock	15050	usd
CY2023Q1	kitl	Issuance Of Financing Commitment Warrants And Exercises IssuanceOfFinancingCommitmentWarrantsAndExercises	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1731	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3849	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1141	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12991	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1007	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1653	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18276	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24865	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55249	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-290238	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	32415	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32415	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22834	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-290238	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24842	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324493	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2008	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	19000	usd
CY2023Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	380860	usd
CY2024Q1	kitl	Reduction Of Accounts Payable And Accrued Interest With Common Stock ReductionOfAccountsPayableAndAccruedInterestWithCommonStock	0	usd
CY2023Q1	kitl	Reduction Of Accounts Payable And Accrued Interest With Common Stock ReductionOfAccountsPayableAndAccruedInterestWithCommonStock	15050	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5117	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22834	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24842	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324493	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2008	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34255	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	380860	usd
CY2024Q1	kitl	Reduction Of Accounts Payable And Accrued Interest With Common Stock ReductionOfAccountsPayableAndAccruedInterestWithCommonStock	0	usd
CY2023Q1	kitl	Reduction Of Accounts Payable And Accrued Interest With Common Stock ReductionOfAccountsPayableAndAccruedInterestWithCommonStock	15050	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zBjdlIHgM3eh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zKIOZ6JPA3Wa">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable and the allowance for doubtful accounts, inventories, valuation of financial instruments, income taxes, and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these condensed consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zBjdlIHgM3eh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zKIOZ6JPA3Wa">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable and the allowance for doubtful accounts, inventories, valuation of financial instruments, income taxes, and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these condensed consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5117	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24842	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3386	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5117	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24842	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3386	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5117	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24842	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	562000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	562000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	562000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	562000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	8067	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11917	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	562000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	562000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	8067	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11917	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	562000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	562000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	8067	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11917	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	8067	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11917	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2024Q1	kitl	Working Capital WorkingCapital	-908324	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2024Q1	kitl	Working Capital WorkingCapital	-908324	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19655070	usd
CY2024Q1	kitl	Equipment Not In Service EquipmentNotInService	0	usd
CY2023Q4	kitl	Equipment Not In Service EquipmentNotInService	40852	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2895	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	57429	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2024Q1	kitl	Working Capital WorkingCapital	-908324	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19655070	usd
CY2023Q4	kitl	Equipment Not In Service EquipmentNotInService	40852	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2895	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2686	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	57429	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2008	usd
CY2024Q1	kitl	Working Capital WorkingCapital	-908324	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19655070	usd
CY2024Q1	kitl	Equipment Not In Service EquipmentNotInService	0	usd
CY2023Q4	kitl	Equipment Not In Service EquipmentNotInService	40852	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2895	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2686	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	57429	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	39363	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60324	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42049	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	352497	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	407500	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	425000	usd
CY2022	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge	100167	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2895	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	57429	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	39363	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60324	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42049	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	352497	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	407500	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	425000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	372920331	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	372920331	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	336763187	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	336763187	shares
CY2024Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	19000	usd
CY2024Q1	kitl	Shares Issued On Equity Line Of Credit Value SharesIssuedOnEquityLineOfCreditValue	32415	usd
CY2023Q4	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	286000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5343	usd
CY2023Q4	kitl	Issuance Of Common Stock As Commitment Fees With Exercise Of Warrants Value IssuanceOfCommonStockAsCommitmentFeesWithExerciseOfWarrantsValue	79977	usd
CY2023Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	52700	usd
CY2023Q3	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	1215000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	34000	usd
CY2023Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	581219	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15072	usd
CY2023Q2	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	980300	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66500	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	234400	usd
CY2023Q2	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	147000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	198000	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	381860	usd
CY2022	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	97453	usd
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3696000	shares
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	58027	usd
CY2024Q1	kitl	Aggregate Cash Proceeds AggregateCashProceeds	450000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16000000	shares
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	39363	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60324	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42049	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	352497	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	352497	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	407500	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	425000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	372920331	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	372920331	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	336763187	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	336763187	shares
CY2024Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	19000	usd
CY2024Q1	kitl	Shares Issued On Equity Line Of Credit Value SharesIssuedOnEquityLineOfCreditValue	32415	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5343	usd
CY2023Q4	kitl	Issuance Of Common Stock As Commitment Fees With Exercise Of Warrants Value IssuanceOfCommonStockAsCommitmentFeesWithExerciseOfWarrantsValue	79977	usd
CY2023Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	52700	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	17000	usd
CY2023Q3	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	1215000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	34000	usd
CY2023Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	581219	usd
CY2023Q3	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	131000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15072	usd
CY2023Q2	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	980300	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66500	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	234400	usd
CY2023Q2	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	147000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	198000	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	381860	usd
CY2023Q1	kitl	Common Stock Issued For Accounts Payable Value CommonStockIssuedForAccountsPayableValue	15050	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	58027	usd
CY2024Q1	kitl	Aggregate Cash Proceeds AggregateCashProceeds	450000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16000000	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	39363	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60324	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	352497	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	407500	usd
CY2022	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge	100167	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	372920331	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	372920331	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	336763187	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	336763187	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	19000	usd
CY2024Q1	kitl	Shares Issued On Equity Line Of Credit Value SharesIssuedOnEquityLineOfCreditValue	32415	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5343	usd
CY2023Q4	kitl	Issuance Of Common Stock As Commitment Fees With Exercise Of Warrants Value IssuanceOfCommonStockAsCommitmentFeesWithExerciseOfWarrantsValue	79977	usd
CY2023Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	52700	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	17000	usd
CY2023Q3	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	1215000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	34000	usd
CY2023Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	581219	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15072	usd
CY2023Q2	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	980300	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66500	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	234400	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	198000	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	381860	usd
CY2023Q1	kitl	Common Stock Issued For Accounts Payable Value CommonStockIssuedForAccountsPayableValue	15050	usd
CY2022	kitl	Issuance Of Common Stock As Financing Commitment Share Shares IssuanceOfCommonStockAsFinancingCommitmentShareShares	1607000	shares
CY2022	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	97453	usd
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3696000	shares
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	58027	usd
CY2024Q1	kitl	Aggregate Cash Proceeds AggregateCashProceeds	450000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16000000	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	372920331	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	372920331	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	336763187	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	336763187	shares
CY2024Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	19000	usd
CY2024Q1	kitl	Shares Issued On Equity Line Of Credit Value SharesIssuedOnEquityLineOfCreditValue	32415	usd
CY2023Q4	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	286000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5343	usd
CY2023Q4	kitl	Issuance Of Common Stock As Commitment Fees With Exercise Of Warrants Value IssuanceOfCommonStockAsCommitmentFeesWithExerciseOfWarrantsValue	79977	usd
CY2023Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	52700	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	17000	usd
CY2023Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	581219	usd
CY2023Q3	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	131000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15072	usd
CY2023Q2	kitl	Stock Based Compensation For Services Related Party Value StockBasedCompensationForServicesRelatedPartyValue	980300	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66500	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	234400	usd
CY2023Q2	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	147000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	198000	usd
CY2022	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	97453	usd
CY2024Q1	kitl	Aggregate Cash Proceeds AggregateCashProceeds	450000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16000000	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-004860-index-headers.html	Edgar Link	pending
0001683168-24-004860-index.html	Edgar Link	pending
0001683168-24-004860.txt	Edgar Link	pending
0001683168-24-004860-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kisses_ex3101.htm	Edgar Link	pending
kisses_ex3102.htm	Edgar Link	pending
kisses_ex3201.htm	Edgar Link	pending
kisses_ex3202.htm	Edgar Link	pending
kisses_i10q-033124.htm	Edgar Link	pending
kitl-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kitl-20240331_cal.xml	Edgar Link	unprocessable
kisses_i10q-033124_htm.xml	Edgar Link	completed
0001683168-24-004860-index-headers.html	Edgar Link	pending
0001683168-24-004860-index.html	Edgar Link	pending
0001683168-24-004860.txt	Edgar Link	pending
0001683168-24-004860-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kisses_ex3101.htm	Edgar Link	pending
kisses_ex3102.htm	Edgar Link	pending
kisses_ex3201.htm	Edgar Link	pending
kisses_ex3202.htm	Edgar Link	pending
kisses_i10q-033124.htm	Edgar Link	pending
kitl-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kitl-20240331_cal.xml	Edgar Link	unprocessable
kitl-20240331_def.xml	Edgar Link	unprocessable
kitl-20240331_lab.xml	Edgar Link	unprocessable
kitl-20240331_pre.xml	Edgar Link	unprocessable
kisses_i10q-033124_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
kitl-20240331_lab.xml	Edgar Link	unprocessable
kitl-20240331_def.xml	Edgar Link	unprocessable
kitl-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KITL
Kisses From Italy Inc. Stock $kitl

2024 Q3 Form 10-Q Financial Statement

#000168316824004860 Filed on July 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITL Kisses From Italy Inc. Stock $kitl

2024 Q3 Form 10-Q Financial Statement

#000168316824004860 Filed on July 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITL
Kisses From Italy Inc. Stock $kitl